Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06395415

Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
46 (estimated)
Sponsor
University of Chicago · Academic / Other
Sex
All
Age
18 Years – 26 Years
Healthy volunteers
Accepted

Summary

Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention. The initial phase of the proposed study uses a pilot study to evaluate a novel mHealth intervention for young adult ENDS and dual product (ENDS and combustible cigarette) users.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEQUIPThe intervention is delivered directly to participants' mobile phones using the Insight® platform, which allows for the implementation of assessments and interventions. Insight has been used in prior mHealth studies and allows for the delivery of tailored content based on parameters, such as intervention stage. The intervention has two stages: 1) Motivational enhancement (weeks 1-2) and 2) Skills and information (weeks 3-6). The first stage of messages will utilize personalized feedback and motivational interviewing prompts, while the second stage will provide health information on ENDS and skills, such as deep breathing. Content is tailored to motivation level (low/medium or high) and dual use status.
BEHAVIORALStandard CareThose in the standard advice group will be given offered a sample of NRT, instruction on its use, and will be encouraged to use in conjunction with standard web-based resources on ENDS and cessation over the course of a ten minute walk-through with study staff.

Timeline

Start date
2025-04-25
Primary completion
2026-03-01
Completion
2026-08-01
First posted
2024-05-02
Last updated
2026-01-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06395415. Inclusion in this directory is not an endorsement.